Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
2017 · Hepatology International · 2,117 citations
https://doi.org/10.1007/s12072-017-9799-9
R
Ryosuke Tateishi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
511
Papers
23.7K
Citations
71
h-index
228
i10-index
Ryosuke Tateishi is an academic researcher from Bunkyo University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Hepatocellular Carcinoma Treatment and Prognosis & Hepatitis C virus research. The author has an h-index of 71, co-authored 435 publications.
ORCID: 0000-0003-3021-2517Papers by this author
worksRadiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations
2006 · Hepatology · 327 citations
https://doi.org/10.1002/hep.21164
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
2018 · Journal of Gastroenterology · 235 citations
https://doi.org/10.1007/s00535-018-1532-5
REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
2019 · Journal of Gastroenterology · 217 citations
https://doi.org/10.1007/s00535-019-01642-1
Surgery versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Randomized Controlled Trial (SURF Trial)
2021 · Liver Cancer · 182 citations
https://doi.org/10.1159/000521665
Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract
2006 · British journal of surgery · 139 citations
https://doi.org/10.1002/bjs.5374
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat